Literature DB >> 9186668

Identification and cloning of genes expressed by human tonsillar B lymphocyte subsets.

J K Frazer1, J LeGros, O de Bouteiller, Y J Liu, J Banchereau, V Pascual, J D Capra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9186668     DOI： 10.1111/j.1749-6632.1997.tb52073.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  CD38 and E2F transcription factor 2 have uniquely increased expression in rheumatoid arthritis synovial tissues.

Authors:  X Chang; L Yue; W Liu; Y Wang; L Wang; B Xu; Y Wang; J Pan; X Yan
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

2.  A novel human B cell subpopulation representing the initial germinal center population to express AID.

Authors:  Grant R Kolar; Darshna Mehta; Rosana Pelayo; J Donald Capra
Journal:  Blood       Date:  2006-11-28       Impact factor: 22.113

Review 3.  Immunoglobulin class-switch recombination deficiencies.

Authors:  Anne Durandy; Sven Kracker
Journal:  Arthritis Res Ther       Date:  2012-07-30       Impact factor: 5.156

4.  Dysregulated miR-155 and miR-125b Are Related to Impaired B-cell Responses in Down Syndrome.

Authors:  Chiara Farroni; Emiliano Marasco; Valentina Marcellini; Ezio Giorda; Diletta Valentini; Stefania Petrini; Valentina D'Oria; Marco Pezzullo; Simona Cascioli; Marco Scarsella; Alberto G Ugazio; Giovanni C De Vincentiis; Ola Grimsholm; Rita Carsetti
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

5.  LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation.

Authors:  Alba Llibre; Constantino López-Macías; Teresa Marafioti; Hema Mehta; Amy Partridge; Carina Kanzig; Felice Rivellese; Jacob D Galson; Lucy J Walker; Paul Milne; Rodney E Phillips; Dominic F Kelly; Gordon J Freeman; Mohey Eldin El Shikh; Paul Klenerman; Christian B Willberg
Journal:  J Immunol       Date:  2016-02-01       Impact factor: 5.422
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.